Sasha Damouni Ellis | Vice President, Investor Relations and Corporate Communications |
Dr. Scott Braunstein | Chief Executive Officer |
Dr. Joe Hulihan | Chief Medical Officer |
Alex Aimetti | Vice President, Scientific Affairs |
Ed Smith | Chief Financial Officer |
Christy Shafer | Chief Commercial Officer |
Kimberly McCormick | Vice President, Regulatory Affairs |
Joseph Thome | Cowen and Company |
Douglas Tsao | H.C. Wainright |
Alethia Young | Cantor |
Joon Lee | Truist Securities |
Marc Goodman | SVB Leerink |
Jay Olson | Oppenheimer |
Ladies and gentlemen, thank you for standing by. And welcome to Marinus Pharmaceuticals Fourth Quarter 2020 Financial Results. At this time, all participant lines are in a listen-only mode. [Operator Instructions] After the speakers’ remarks, there will be a question-and-answer session. [Operator Instructions] I would now like to turn the call over to Sasha Damouni, Vice President of Investor Relations and Corporate Communications.